Literature DB >> 2851193

The influence of carbohydrate structure on the clearance of recombinant tissue-type plasminogen activator.

A Hotchkiss1, C J Refino, C K Leonard, J V O'Connor, C Crowley, J McCabe, K Tate, G Nakamura, D Powers, A Levinson.   

Abstract

Modification of the carbohydrate structures of recombinant tissue-type plasminogen activator (rt-PA) can increase or decrease its rate of clearance in rabbits. When rt-PA was treated with sodium periodate to oxidize carbohydrate residues, the rate of clearance was decreased from 9.6 +/- 1.9 ml min-1 kg-1 to 3.5 +/- 0.6 ml min-1 kg-1 (mean +/- SD, n = 5). A similar change in the clearance of rt-PA was introduced by the use of endo-beta-N-acetyl-glucosaminidase H (Endo-H), which selectively removes high mannose asparagine-linked oligosaccharides; the clearance of Endo-H-treated rt-PA was 5.0 +/- 0.5 ml min-1 kg-1. A mutant of rt-PA was produced with an amino acid substitution at position 117 (Asn replaced with Gln) to remove a potential glycosylation site that normally contains a high mannose structure. The clearance of this material was also decreased, similar to the periodate and Endo-H-treated rt-PA. Conversely, when rt-PA was produced in the CHO 15B cell line, which can produce only high mannose oligosaccharide structures on glycoproteins, the clearance was increased by a factor of 1.8. These results demonstrate that the removal of rt-PA from the blood depends significantly upon the nature of its oligosaccharide structures.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2851193

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  A faster-acting and more potent form of tissue plasminogen activator.

Authors:  B A Keyt; N F Paoni; C J Refino; L Berleau; H Nguyen; A Chow; J Lai; L Peña; C Pater; J Ogez
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

2.  Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.

Authors:  J Krause; W Seydel; G Heinzel; P Tanswell
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

3.  Expression of a novel chimeric truncated t-PA in CHO cells based on in silico experiments.

Authors:  Fatemeh Davami; Soroush Sardari; Keivan Majidzadeh-A; Mehdi Hemayatkar; Farzaneh Barkhrdari; Maryam Omidi; Mehrnaz Azami; Ahmad Adeli; Noushin Davoudi; Fereidoun Mahboudi
Journal:  J Biomed Biotechnol       Date:  2010-09-22

4.  Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins.

Authors:  J Mordenti; S A Chen; J A Moore; B L Ferraiolo; J D Green
Journal:  Pharm Res       Date:  1991-11       Impact factor: 4.200

5.  Pharmacokinetic and thrombolytic properties of unglycosylated recombinant tissue-type plasminogen activator (BM 06.021) produced in Escherichia coli.

Authors:  U Martin; S Fischer; U Kohnert; U Opitz; R Rudolph; G Sponer; A Stern; K Strein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-07       Impact factor: 3.000

6.  Intrinsic glycosylation potentials of insect cell cultures and insect larvae.

Authors:  T R Davis; H A Wood
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-10       Impact factor: 2.416

7.  Evidence for carbohydrate-independent endocytosis of tissue-type plasminogen activator by liver cells.

Authors:  E Stang; N Roos; M Schlüter; T Berg; J Krause
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

8.  In vivo kinetics of 99mTc labeled recombinant tissue plasminogen activator in rabbits.

Authors:  K Itoh; M Ieko; E Hiraguchi; H Kitayama; E Tsukamoto
Journal:  Ann Nucl Med       Date:  1994-08       Impact factor: 2.668

9.  Structural analysis and localization of the carbohydrate moieties of a soluble human interferon gamma receptor produced in baculovirus-infected insect cells.

Authors:  M Manneberg; A Friedlein; H Kurth; H W Lahm; M Fountoulakis
Journal:  Protein Sci       Date:  1994-01       Impact factor: 6.725

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.